These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30285261)

  • 41. Treating opioid use disorders during pregnancy: historical, current, and future directions.
    Jones HE
    Subst Abus; 2013; 34(2):89-91. PubMed ID: 23577898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
    Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
    J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating Buprenorphine Into an Opioid Treatment Program: Tailoring Care for Patients With Opioid Use Disorders.
    Polydorou S; Ross S; Coleman P; Duncan L; Roxas N; Thomas A; Mendoza S; Hansen H
    Psychiatr Serv; 2017 Mar; 68(3):295-298. PubMed ID: 27745534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care.
    Goodman D
    J Midwifery Womens Health; 2011; 56(3):240-7. PubMed ID: 21535372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of buprenorphine treatment for opioid dependence.
    Murphy SM; Fishman PA; McPherson S; Dyck DG; Roll JR
    J Subst Abuse Treat; 2014 Mar; 46(3):315-9. PubMed ID: 24209382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
    Pan A; Zakowski M
    Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.
    Bhatraju EP; Grossman E; Tofighi B; McNeely J; DiRocco D; Flannery M; Garment A; Goldfeld K; Gourevitch MN; Lee JD
    Addict Sci Clin Pract; 2017 Feb; 12(1):7. PubMed ID: 28245872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis.
    King JB; Sainski-Nguyen AM; Bellows BK
    J Pain Palliat Care Pharmacother; 2016; 30(1):55-65. PubMed ID: 27007583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.
    Bastian JR; Chen H; Zhang H; Rothenberger S; Tarter R; English D; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Jan; 216(1):64.e1-64.e7. PubMed ID: 27687214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioid addiction in pregnancy.
    Shainker SA; Saia K; Lee-Parritz A
    Obstet Gynecol Surv; 2012 Dec; 67(12):817-25. PubMed ID: 23233054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Buprenorphine maintenance in pregnant opiate addicts.
    Fischer G; Etzersdorfer P; Eder H; Jagsch R; Langer M; Weninger M
    Eur Addict Res; 1998; 4 Suppl 1():32-6. PubMed ID: 9767205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: a cross-sectional survey of drug using prisoners.
    Wright NM; Mohammed Z; Hughes GJ
    Drug Alcohol Depend; 2014 Nov; 144():254-8. PubMed ID: 25305714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.